Lexicon Pharmaceuticals Inc. (LXRX)

3.19
0.06 1.70
NASDAQ : Health Technology
Prev Close 3.24
Open 3.24
Day Low/High 3.15 / 3.34
52 Wk Low/High 1.12 / 9.33
Volume 1.28M
Avg Volume 2.53M
Exchange NASDAQ
Shares Outstanding 106.27M
Market Cap 350.70M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
First Week of LXRX February 2018 Options Trading

First Week of LXRX February 2018 Options Trading

Investors in Lexicon Pharmaceuticals, Inc. saw new options become available this week, for the February 2018 expiration.

First Week Of July 2018 Options Trading For Lexicon Pharmaceuticals (LXRX)

First Week Of July 2018 Options Trading For Lexicon Pharmaceuticals (LXRX)

Investors in Lexicon Pharmaceuticals, Inc. saw new options become available this week, for the July 2018 expiration.

Short Interest Declines 13.8% For LXRX

Short Interest Declines 13.8% For LXRX

The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 2,150,673 share decrease in total short interest for Lexicon Pharmaceuticals, Inc. , to 13,435,509, a decrease of 13.80% since 10/13/2017.

First Week of LXRX December 15th Options Trading

First Week of LXRX December 15th Options Trading

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading this week, for the December 15th expiration.

LXRX: Insiders vs. Shorts

LXRX: Insiders vs. Shorts

The most recent short interest data was recently released for the 08/31/2017 settlement date, and Lexicon Pharmaceuticals, Inc. is one of the most shorted stocks of the Russell 3000, based on 31.32 "days to cover" versus the median component at 6.19.

Biotech Mailbag: Buy Dip in T2 Biosystems?

Biotech Mailbag: Buy Dip in T2 Biosystems?

Plus, what's going on with Lexicon Pharmaceuticals?

Interesting LXRX Put And Call Options For September 15th

Interesting LXRX Put And Call Options For September 15th

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading today, for the September 15th expiration.

Interesting LXRX Put And Call Options For August 18th

Investors in Lexicon Pharmaceuticals, Inc. saw new options become available this week, for the August 18th expiration.

First Week of January 2018 Options Trading For Lexicon Pharmaceuticals (LXRX)

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading this week, for the January 2018 expiration.

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Karyopharm Therapeutics falls 18%; Lexicon rises on drug approval.

4 Smaller Biotech Names Worth Researching

4 Smaller Biotech Names Worth Researching

Here's why to check out Dynavax Technologies as well Lexicon, Supernus and Acadia Pharmaceuticals.

7 Things to Watch in Biotech Now

7 Things to Watch in Biotech Now

M&A, drug approvals and Trump are all on my watch list.

These 3 Biotech Stocks Are Already Moving Wildly on Thursday

These 3 Biotech Stocks Are Already Moving Wildly on Thursday

Here are some names that have caught our eye.

First Week of LXRX February 2017 Options Trading

First Week of LXRX February 2017 Options Trading

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading this week, for the February 2017 expiration.

Notable Friday Option Activity: LXRX, WTW, XBIT

Notable Friday Option Activity: LXRX, WTW, XBIT

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Lexicon Pharmaceuticals, Inc. , where a total volume of 6,103 contracts has been traded thus far today, a contract volume which is representative of approximately 610,300 underlying shares (given that every 1 contract represents 100 underlying shares).

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AYR, CRCM, TG Downgrades: ADPT, AMZN, ANGI, ARNC, BKD, BWXT, CAJ, CALX, CSGP, EMR, HZO, LXRX, MNK, MYGN, NTRA, PBI, TCO, TRI Initiations: PFGC Read on to get TheStreet Quant Ratings' detailed report:

Short Interest In Lexicon Pharmaceuticals Moves 16% Higher

Short Interest In Lexicon Pharmaceuticals Moves 16% Higher

The most recent short interest data has been released for the 09/30/2016 settlement date, which shows a 2,011,299 share increase in total short interest for Lexicon Pharmaceuticals, Inc. , to 14,608,790, an increase of 15.97% since 09/15/2016.

First Week Of LXRX August 19th Options Trading

First Week Of LXRX August 19th Options Trading

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading this week, for the August 19th expiration.

7 Stocks Spiking on Big Volume

7 Stocks Spiking on Big Volume

Here's a technical look at how to trade seven stocks rising on unusual volume.

Lexicon Pharmaceuticals (LXRX) Weak On High Volume Today

Lexicon Pharmaceuticals (LXRX) Weak On High Volume Today

Trade-Ideas LLC identified Lexicon Pharmaceuticals (LXRX) as a weak on high relative volume candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BOBE, CETX, CTL, FNV, GRMN, INT, IVR, KE, LNN, LXRX, MCY, MEET, MNK, NVMI, SAVE, VIAV, WFM, Y, ZBH Downgrades: CHUY, FLO, LNCE, SYNL, WMB, WMC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Strong On High Volume: Lexicon Pharmaceuticals (LXRX)

Strong On High Volume: Lexicon Pharmaceuticals (LXRX)

Trade-Ideas LLC identified Lexicon Pharmaceuticals (LXRX) as a strong on high relative volume candidate

Lexicon Pharmaceuticals Enters Oversold Territory (LXRX)

Lexicon Pharmaceuticals Enters Oversold Territory (LXRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Short Interest Falls 10.8% For LXRX

Short Interest Falls 10.8% For LXRX

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 1,541,247 share decrease in total short interest for Lexicon Pharmaceuticals, Inc. , to 12,802,214, a decrease of 10.75% since 12/15/2015.

Stock To Watch: Lexicon Pharmaceuticals (LXRX) In Perilous Reversal

Stock To Watch: Lexicon Pharmaceuticals (LXRX) In Perilous Reversal

Trade-Ideas LLC identified Lexicon Pharmaceuticals (LXRX) as a "perilous reversal" (up big yesterday but down big today) candidate

Today's Weak On High Volume Stock: Lexicon Pharmaceuticals (LXRX)

Today's Weak On High Volume Stock: Lexicon Pharmaceuticals (LXRX)

Trade-Ideas LLC identified Lexicon Pharmaceuticals (LXRX) as a weak on high relative volume candidate

10 Best Nasdaq Biotech Stocks in the Third Quarter

10 Best Nasdaq Biotech Stocks in the Third Quarter

Here are the 10 stocks in the biotech sector which had the best third-quarter.

TheStreet Quant Rating: D- (Sell)